– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...

October 16, 2009 — Clinicians should consider magnetic resonance imaging (MRI) for men who have elevated prostate-specific antigen (PSA) levels or some other "worrisome" prostate cancer variable, but ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Aaron ...

Maple Grove. Minn.-based Francis Medical has announced that Aaron Milbank, MD, performed the first commercial procedure in the Midwest using its Vanquish Water Vapor Ablation System at High Pointe ...

Mar 27, 2026, 7:45 AM ETProfound Medical Corp. (PROF), PRN:CA The TULSA Procedure, performed using the TULSA-PRO ® system, represents a major advancement in prostate care, and is used by physicians to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...